Sarepta Therapeutics
SRPT
#4401
Rank
NZ$4.03 B
Marketcap
NZ$38.53
Share price
-2.45%
Change (1 day)
-82.05%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - P/B ratio

P/B ratio as of December 2025 : 1.76

According to Sarepta Therapeutics 's latest financial reports the company has a price-to-book ratio of 0.960062.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Sarepta Therapeutics - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-31N/A-100%
2024-12-317.60-27.63%
2023-12-3110.5-64.47%
2022-12-3129.5249.71%
2021-12-318.45-52.16%
2020-12-3117.748.95%
2019-12-3111.957.82%
2018-12-317.5164.9%
2017-12-314.562.45%
2016-12-314.45-51.91%
2015-12-319.25283.15%
2014-12-312.41-22.41%
2013-12-313.11-52.96%
2012-12-316.61102.84%
2011-12-313.26-103.86%
2010-12-31-84.6-1338.5%
2009-12-316.83129.38%
2008-12-312.98-13.59%
2007-12-313.44-23.19%
2006-12-314.4836.28%
2005-12-313.291.78%
2004-12-313.230.02%
2003-12-313.23-42.85%
2002-12-315.66

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Gilead Sciences
GILD
7.02 300.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-7.07-502.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
5.73 226.42%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-4.07-332.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
258 14,607.70%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
-39.9-2,370.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Insmed
INSM
46.2 2,534.06%๐Ÿ‡บ๐Ÿ‡ธ USA